X hits on this document

Powerpoint document

PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES - page 23 / 38

100 views

0 shares

0 downloads

0 comments

23 / 38

Antiplatlet Agents-Secondary Prevention, Class 1

ASA in existing CVD reduces subsequent risk by 25%

Unless contraindicated, ASA should be used by most patients

Clopidigril and ticlopidine should be considered for patients with ASA allergy or intolerance

Cost

ASA $11,000/QALY

Clopidigril $130,000/QALY

Document info
Document views100
Page views100
Page last viewedFri Dec 09 01:04:25 UTC 2016
Pages38
Paragraphs624
Words2577

Comments